SCHEMBL4349997

SCHEMBL4349997

O=C(/C=C/c1c[nH]c2ncccc12)NC(Cc1ccccc1)CN1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.47
KMT2A Q03164 2/20 0.39
ADORA2A P29274 1/20 0.38
MAPT P10636 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TP53 P04637 1/20 0.37
MET P08581 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HTR1A P08908 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355315 1.00 GSK3B (0.47) GSK3BKMT2AADORA2AMAPTNPSR1
SCHEMBL4350005 1.00 GSK3B (0.47) GSK3BKMT2AADORA2AMAPTNPSR1
SCHEMBL4355310 1.00 GSK3B (0.47) GSK3BKMT2AADORA2AMAPTNPSR1
SCHEMBL4352493 0.92 GSK3B (0.45) GSK3BKMT2AADORA2ADRD4HTR1A
SCHEMBL4352488 0.92 GSK3B (0.45) GSK3BKMT2AADORA2ADRD4HTR1A
SCHEMBL4353050 0.88 KDM4E (0.40) GSK3BKMT2AMAPTNPSR1TP53
SCHEMBL4353056 0.88 KDM4E (0.40) GSK3BKMT2AMAPTNPSR1TP53
SCHEMBL4350722 0.86 AURKA (0.46) GSK3BKMT2ATP53DRD2DRD4
SCHEMBL4350717 0.86 AURKA (0.46) GSK3BKMT2ATP53DRD2DRD4
SCHEMBL4351445 0.86 GSK3B (0.62) GSK3BKMT2AADORA2AMETHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 EP claimed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 EP disclosed